Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 1 1

Status

Completed 18Terminated 3Active not recruiting 3Unknown 1Recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Flutamide × Clear all
NCT00651326 2023-08-04

DART

Canadian Cancer Trials Group

Phase 3 Terminated
48 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003645 2020-04-28

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

M.D. Anderson Cancer Center

Phase 3 Terminated
64 enrolled 12 charts
Genitourinary

Prostatic Neoplasms

NCT00388804 2012-08-08

External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

M.D. Anderson Cancer Center

Phase 3 Terminated
39 enrolled 3 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡